{"id":"W4317863296","doi":"10.1200/jco.2023.41.4_suppl.106","title":"A phase 1 study of E7386, a CREB-binding protein (CBP)/β-catenin interaction inhibitor, in patients (pts) with advanced solid tumors including colorectal cancer: Updated dose-escalation part.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Eisai Canada","keywords":"Medicine; Tolerability; Adverse effect; Response Evaluation Criteria in Solid Tumors; Internal medicine; Colorectal cancer; Pharmacokinetics; Pharmacodynamics; Oncology; Cancer; Pharmacology; Phases of clinical research; Clinical trial","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001188857,0.001138803,0.001306685,0.000535538,0.0003046543,0.000670561,0.0006694627,0.000872681,0.002784911],"category_scores_gemma":[0.0006089508,0.0004598513,0.0008702481,0.0006211897,0.0003722017,0.0005261911,0.0002794978,0.002181995,0.0007055091],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007401811,"about_ca_system_score_gemma":0.001382396,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007312211,"about_ca_topic_score_gemma":0.002267267,"domain_scores_codex":[0.9996462,0.0001518644,0.00002296584,0.00006273045,0.00005584398,0.00006029312],"domain_scores_gemma":[0.9996994,0.00004905405,0.00007443458,0.00003133423,0.00003987861,0.0001059094],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3561912,0.08693314,0.01277016,0.002181325,0.002683981,0.0008666239,0.0005557032,0.007378984,0.155088,0.0006999376,0.01440604,0.3602448],"study_design_scores_gemma":[0.4027711,0.5168873,0.03220605,0.0001001067,0.001619872,0.001513847,0.00009355049,0.003136335,0.01754887,0.0004632585,0.02358175,0.000078016],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.975395,0.005479527,0.00202853,0.0007737448,0.0001290696,0.007808795,0.003866701,0.0002511931,0.004267413],"genre_scores_gemma":[0.9616976,0.006463027,0.007225809,0.002160288,0.0001433924,0.006035837,0.01035436,0.00008584977,0.005833897],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002784911,"threshold_uncertainty_score":0.009316444,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08887203526624725,"score_gpt":0.5075697103502357,"score_spread":0.4186976750839884,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}